Printed Electronics for Life Sciences (Printed Electronics USA 2007)

Dr. Bokhari brings extensive entrepreneurial experience in adoption and commercialization of emerging materials and nanotechnology to BIOIDENT.

 

Wasiq Bokhari was a co-founder and managing partner of Quantum Insight. He worked with Fortune 500 companies on the adoption and commercialization of materials and nanotechnology with applications in energy, IT and medicine. Wasiq also works with entrepreneurs and early-stage startups in technology commercialization.

 

He is a serial entrepreneur with extensive experience in the field of emerging materials and nanotechnology. He served as a strategic advisor to Chevron and was part of the team that built and grew Molecular Diamond Technologies, a new nanomaterials focused business unit. He also served as a strategic advisor to Hitachi in the areas of emerging electronics, energy and life sciences applications. He was part of the founding team and interim CEO of Kalinex Inc., a drug discovery instrumentation company. Prior to that, he Seite 2/3 was part of the founding team and Senior Vice President of Products of Clickmarks, an enterprise infrastructure software company, subsequently acquired by Semotus Solutions.

 

Wasiq received his Ph.D. in physics from the Massachusetts Institute of Technology, under Nobel laureate Jerome Friedman. He was part of the team that discovered a fundamental particle called the top quark at the Fermi National Accelerator Laboratory in 1995. He is an author of more than 50 scientific and technical publications, and is cited as an inventor on 8 patents, granted and applied. He is also the co-founder and Steering Committee Chair of the MIT Stanford UC Berkeley Nanotechnology Forum. Wasiq has worked with PCAST (Presidential Council of Advisors on Science and Technology) on issues related to energy. PCAST is the highest civilian body that advises the US President on issues in science and technology.

BIOIDENT is the leader in the development of rapid, multi-assay and mobile analytical and diagnostic systems. BIOIDENT integrates highly sensitive printed photodetectors and electronics with various existing Lab-on-a-Chip (LOC) technologies including lateral flow, microfluidics and microarrays.

 

BIOIDENT's systems are designed for applications in in-vitro diagnostics chemical./biological threat detection and environmental testing. BIOIDENT's award winning Photonic Lab™ Technology Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays. Benefits for BIOIDENT's customers and partners include high mobility, rapid testing, multi-plexing and low cost of ownership.

 

BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG, the world leader in printed opto-electronics. The company is privately held with headquarters in Menlo Park, California. BIOIDENT leverages NANOIDENT's SEMICONDUCTOR 2.0™ Platform technology and its high-speed manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an inkjet printer. NANOIDNET also has the world's only dedicated organic fabrication facility with a production output of 40,000 sq.m per year. For more information about the company, please visit www.BIOIDENT.com.